{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmoving-digital-health.simplecast.com%2Fepisodes%2Fep-44-l_pRuJwT","width":444,"version":"1.0","type":"rich","title":"How Agentic AI is Reshaping Clinical Trials (And Why Most Pilots Still Fail)","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/720fc301-ad35-4a99-90ef-ddf2146c6328/ebdd2625-6bec-4cd9-a2aa-c18df97d46fe/thumbnail-mdh-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f1116b23-62e0-46e3-985b-29e92c05438c\" height=\"200\" width=\"100%\" title=\"How Agentic AI is Reshaping Clinical Trials (And Why Most Pilots Still Fail)\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Most digital health pilots never make it to production, and according to Dr. Anastasia Christianson, the reason usually has nothing to do with the AI itself.\n\nDr. Christianson has led AI and global informatics at Pfizer and Johnson & Johnson, and now advises healthcare organizations on agentic AI and clinical trial design.\n\nIn this episode of Moving Digital Health, Dr. Christianson joins MindSea CEO Reuben Hall to talk through why most pilots never find a path to P&L. They also cover the real question clinician-founders should ask before going all-in: do you love the business problem, or the clinical solution?"}